Although previous research has shown beneficialeffect of PPARγ agonists in PCOS, this is thefirst study to examine the combined effect of EPAand rFSH on the gene expression levels of PPARγand CYP-19 in human GC. Here, PPARG is linked to polycystic ovary syndrome.